Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 80

1.

Retraction: FRA-1 Expression in Hyperplastic and Neoplastic Thyroid Diseases.

Chiappetta G, Tallini G, De Biasio MC, Pentimalli F, de Nigris F, Losito S, Fedele M, Battista S, Verde P, Santoro M, Fusco A.

Clin Cancer Res. 2019 Apr 15;25(8):2675. doi: 10.1158/1078-0432.CCR-19-0487. No abstract available.

PMID:
30988099
2.

Dual Oncogenic/Anti-Oncogenic Role of PATZ1 in FRTL5 Rat Thyroid Cells Transformed by the Ha-RasV12 Oncogene.

Vitiello M, Palma G, Monaco M, Bello AM, Camorani S, Francesca P, Rea D, Barbieri A, Chiappetta G, Vita G, Cerchia L, Arra C, Fedele M.

Genes (Basel). 2019 Feb 9;10(2). pii: E127. doi: 10.3390/genes10020127.

3.

Retraction: Haploinsufficiency of the Hmga1 Gene Causes Cardiac Hypertrophy and Myelo-Lymphoproliferative Disorders in Mice.

Fedele M, Fidanza V, Battista S, Pentimalli F, Klein-Szanto AJP, Visone R, De Martino I, Curcio A, Morisco C, Del Vecchio L, Baldassarre G, Arra C, Viglietto G, Indolfi C, Croce CM, Fusco A.

Cancer Res. 2018 Dec 15;78(24):6908. doi: 10.1158/0008-5472.CAN-18-3457. No abstract available.

PMID:
30552126
4.

Retraction: HMGA Proteins Up-regulate CCNB2 Gene in Mouse and Human Pituitary Adenomas.

De Martino I, Visone R, Wierinckx A, Palmieri D, Ferraro A, Cappabianca P, Chiappetta G, Forzati F, Lombardi G, Colao A, Trouillas J, Fedele M, Fusco A.

Cancer Res. 2018 Dec 15;78(24):6906. doi: 10.1158/0008-5472.CAN-18-3455. No abstract available.

PMID:
30552124
5.

Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer.

Camorani S, Hill BS, Collina F, Gargiulo S, Napolitano M, Cantile M, Di Bonito M, Botti G, Fedele M, Zannetti A, Cerchia L.

Theranostics. 2018 Oct 6;8(18):5178-5199. doi: 10.7150/thno.27798. eCollection 2018.

6.

TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities.

Camorani S, Fedele M, Zannetti A, Cerchia L.

Pharmaceuticals (Basel). 2018 Nov 13;11(4). pii: E123. doi: 10.3390/ph11040123. Review.

7.

Trabectedin modulates the senescence-associated secretory phenotype and promotes cell death in senescent tumor cells by targeting NF-κB.

Camorani S, Cerchia L, Fedele M, Erba E, D'Incalci M, Crescenzi E.

Oncotarget. 2018 Apr 13;9(28):19929-19944. doi: 10.18632/oncotarget.24961. eCollection 2018 Apr 13.

8.

Loss of One or Two PATZ1 Alleles Has a Critical Role in the Progression of Thyroid Carcinomas Induced by the RET/PTC1 Oncogene.

Monaco M, Palma G, Vitiello M, Capiluongo A, D'Andrea B, Vuttariello E, Luciano A, Cerchia L, Chiappetta G, Arra C, Fusco A, Fedele M.

Cancers (Basel). 2018 Mar 27;10(4). pii: E92. doi: 10.3390/cancers10040092.

9.

Oligonucleotide aptamers against tyrosine kinase receptors: Prospect for anticancer applications.

Camorani S, Crescenzi E, Fedele M, Cerchia L.

Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):263-277. doi: 10.1016/j.bbcan.2018.03.003. Epub 2018 Mar 21. Review.

PMID:
29574128
10.

Retraction for Melillo et al., "Critical Role of the HMGI(Y) Proteins in Adipocytic Cell Growth and Differentiation".

Melillo RM, Pierantoni GM, Scala S, Battista S, Fedele M, Stella A, De Biasio MC, Chiappetta G, Fidanza V, Condorelli G, Santoro M, Croce CM, Viglietto G, Fusco A.

Mol Cell Biol. 2018 Feb 27;38(6). pii: e00660-17. doi: 10.1128/MCB.00660-17. Print 2018 Mar 15. No abstract available.

11.

The POZ/BTB and AT-Hook Containing Zinc Finger 1 (PATZ1) Transcription Regulator: Physiological Functions and Disease Involvement.

Fedele M, Crescenzi E, Cerchia L.

Int J Mol Sci. 2017 Nov 24;18(12). pii: E2524. doi: 10.3390/ijms18122524. Review.

12.

HMGA2 cooperates with either p27kip1 deficiency or Cdk4R24C mutation in pituitary tumorigenesis.

Fedele M, Paciello O, De Biase D, Monaco M, Chiappetta G, Vitiello M, Barbieri A, Rea D, Luciano A, Papparella S, Arra C, Fusco A.

Cell Cycle. 2018;17(5):580-588. doi: 10.1080/15384101.2017.1403682. Epub 2018 Jan 30.

13.

The Epithelial-to-Mesenchymal Transition in Breast Cancer: Focus on Basal-Like Carcinomas.

Fedele M, Cerchia L, Chiappetta G.

Cancers (Basel). 2017 Sep 30;9(10). pii: E134. doi: 10.3390/cancers9100134. Review.

14.

PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype.

Guadagno E, Vitiello M, Francesca P, Calì G, Caponnetto F, Cesselli D, Camorani S, Borrelli G, Califano M, Cappabianca P, Arra C, Crescenzi E, Cerchia L, De Caro MLDB, Fedele M.

Oncotarget. 2017 Jul 25;8(35):59282-59300. doi: 10.18632/oncotarget.19546. eCollection 2017 Aug 29.

15.

Survival of cancer patients in Italy.

Coviello V, Buzzoni C, Fusco M, Barchielli A, Cuccaro F, De Angelis R, Giacomin A, Luminari S, Randi G, Mangone L; AIRTUM Working Group.

Epidemiol Prev. 2017 Mar-Apr;41(2 Suppl 1):1-244. doi: 10.19191/EP17.2S1.P001.017. English, Italian.

16.

Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers.

Camorani S, Crescenzi E, Gramanzini M, Fedele M, Zannetti A, Cerchia L.

Sci Rep. 2017 Apr 20;7:46659. doi: 10.1038/srep46659.

17.

POZ-, AT-hook-, and zinc finger-containing protein (PATZ) interacts with the human oncogene B cell lymphoma 6 (BCL6) and is required for its negative autoregulation.

Pero R, Palmieri D, Angrisano T, Valentino T, Federico A, Franco R, Lembo F, Klein-Szanto AJ, Del Vecchio L, Montanaro D, Keller S, Arra C, Papadopoulou V, Wagner SD, Croce CM, Fusco A, Chiariotti L, Fedele M.

J Biol Chem. 2017 Mar 31;292(13):5609. doi: 10.1074/jbc.A117.346270. No abstract available.

18.

Complementary actions of dopamine D2 receptor agonist and anti-vegf therapy on tumoral vessel normalization in a transgenic mouse model.

Chauvet N, Romanò N, Lafont C, Guillou A, Galibert E, Bonnefont X, Le Tissier P, Fedele M, Fusco A, Mollard P, Coutry N.

Int J Cancer. 2017 May 1;140(9):2150-2161. doi: 10.1002/ijc.30628. Epub 2017 Feb 14.

19.

Animal Models of Human Pathology 2016.

Fedele M, Gualillo O, Vecchione A.

Biomed Res Int. 2016;2016:4023982. doi: 10.1155/2016/4023982. Epub 2016 Dec 22. No abstract available.

20.

A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expression.

Chiefari E, Ventura V, Capula C, Randazzo G, Scorcia V, Fedele M, Arcidiacono B, Nevolo MT, Bilotta FL, Vitiello M, Palmieri C, Gulletta E, Fusco A, Foti D, Vero R, Brunetti A.

Sci Rep. 2016 Dec 19;6:39429. doi: 10.1038/srep39429.

Supplemental Content

Loading ...
Support Center